ON_348_banner

Improving Patient Outcomes in Non-Melanoma Skin Cancers: Advances in Checkpoint Inhibition, Risk Stratification, and Patient-Centered Care

ASCO 2026 ENCOMPASS Experience:
An Immersive Exploration of the Latest in Oncology Care
A Part of the ENCOMPASS Initiative

FACULTY

Professor Danny Rischin, FAHMS
Director, Medical Oncology
Peter MacCallum Cancer Centre
Australian Academy of Health and Medical Sciences

PROGRAM OVERVIEW

This program is designed to address persistent clinical gaps in the management of nonmelanoma skin cancers (NMSCs), particularly in identifying and treating high-risk disease. The program is structured to improve clinicians’ knowledge, competence, and confidence by enabling them to identify key diagnostic and stratification criteria to promptly and accurately recognize high-risk NMSC. Building on this foundation, the education integrates current clinical data for emerging neoadjuvant and adjuvant immunotherapies, supporting clinicians in incorporating these approaches into treatment strategies to optimize surgical outcomes and reduce recurrence risk. Additionally, the program emphasizes the importance of coordinated, patient-centered care by developing strategies for clinicians to work effectively within the multidisciplinary team and engage patients in shared decision-making, ultimately enhancing communication, care alignment, and overall outcomes in high-risk NMSC management.

TARGET AUDIENCE

This activity is designed to meet the educational needs of clinicians who are involved in the management of patients with NMSCs. This may include dermato-oncologists, oncologists, and surgeons with varying skin cancer-specific expertise, and associated advanced practice providers (APPs; e.g., oncology nurses, nurse practitioners, and physician assistants), and other clinicians involved in the treatment and care of patients with NMSC.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

  • Identify key diagnostic and stratification criteria to promptly and accurately identify high-risk NMSC
  • Integrate clinical data for emerging neoadjuvant and adjuvant immunotherapies for NMSC into treatment strategies
  • Develop strategies to work closely within the multidisciplinary team, and with the patient, to optimize patient care

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: June 05, 2026
EXPIRATION DATE: June 05, 2027

Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

Healthcare Business Review Award

We are thrilled to announce that we have been recognized as one of the Top 10 Health Education Services Providers by Healthcare Business Review!

This award is both an honor and a testament to our cumulative dedication to providing the best continuing medical education (CME) services to HCPs across the globe. We are proud to be part of this distinguished group and look forward to continuing to have MLG be one of the best CME providers in the country.

Thank you to Healthcare Business Review for this recognition and for shining a light on the importance of accurate and accessible healthcare education.

#TopHealthEducationProvider #MedLearningGroup #HealthcareBusinessReview #MedicalEducation
BestofAmerica

Best of America Small Business Awards
Best Website

The Best of America Small Business Website award recognizes the best website launched by a small business since 2021. Technology is a key growth enabler for small businesses. The best in tech track recognizes small businesses as experts in technology and innovation from innovators, app developers, and website creators. Visit our award-winning Ophthalmology and Optometry web portal: vision-relief.com

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.